Navigation Links
Cheaper and easier isn't necessarily better in new colon cancer screening procedures
Date:10/20/2011

Eventually, colon cancers bleed and so tests for blood in stool seem an inexpensive and noninvasive alternative to traditional colonoscopies. In fact, a recent article in the journal Cancer Prevention Research showed that fecal immunochemical testing (FIT) is an accurate predictor of colorectal cancer and can provide a low-cost screening alternative for medically underserved populations.

However, Tim Byers, MD, MPH, investigator at the University of Colorado Cancer Center and professor of epidemiology at the Colorado School of Public Health, says that despite its ease, low cost, and one-time accuracy, FIT remains inferior to colorectal cancer screening the old-fashioned way, by colonoscopy.

Here's why.

"Testing for blood in the stool can find cancer and advanced adenomas, but it does not work well for finding most adenomas, therefore creates many missed opportunities for cancer prevention," Byers says. In other words, by the time a colorectal cancer bleeds, the window for successful treatment may be closed proverbially, this is discovering the barn door is unlocked after the horse has run away.

To shorten the time before a bleeding colorectal cancer sees treatment, proponents of FIT testing recommend using the procedure yearly, rather than every five-to-ten years as recommended for colonoscopies. Frequent screening, they hope, will allow treatment to follow closely on the heels of the discovery of blood in stool, perhaps with the same timeliness of a colonoscopy, which due to the long time between screenings may catch a cancer that has been on the move for years between checks.

However, "We are very bad in our health care system and as individuals in doing anything yearly, so practices that use FIT testing perform poorly with repeat testing over time the poor performance of FIT testing gets even worse as people forget to do the annual tests," Byers says.

In a recent editorial in response to the findings in the above journal, Byers points out that insurance companies have strong incentive to promote the less expensive alternative, but in this case the cheaper alternative may, in fact, lead to fewer colorectal cancers identified in their early stages.

"Tests designed to identify occult blood in the stool are better for detecting colorectal cancer, whereas direct endoscopic visualization of the colorectum [colonoscopy] is better for prevention," Byers writes.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. Foam injections for varicose veins better for patients and cheaper, study finds
2. Cheaper DNA Sequencing Coming Closer
3. Cheaper, Older Treatment for Vasculitis Beats Out New Drug
4. Many HIV-Infected Kids Could Use Cheaper Treatment Safely
5. Mathematical models for breast cancer detection with microwave tomography are cheaper and less risky
6. Simpler and cheaper antibiotic prophylaxis with insertion of nutrition catheter in the stomach
7. Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting
8. Vacuum-like device makes cellular exploration easier
9. Sound localization at cocktail parties is easier for men
10. Guidelines for ventilator use help premature infants breathe easier
11. U.S. Makes It Easier to Get Insurance With Pre-Existing Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators ... often saves lives. However, if one isn’t accessible in certain locations, the risk ... defibrillation, I came up with this idea," said an inventor from Ridgecrest, Calif. ...
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE is pleased ...  , Molli C., a graduate student from Sonora, California, who will begin her ... St. Thomas University in Miami, Florida, was selected from a pool of more ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... rooms is celebrating the one year anniversary of its Houston-Fallbrook facility. , ... Dr. Otinwa, Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has ...
(Date:9/22/2017)... CA (PRWEB) , ... September 22, 2017 , ... ... groceries, wearable, and more products at customers’ doorstep. According to Smart Mart, customers ... Mart has stated to offer wearable, and customers can find clothing at discounted ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality ... run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves staring ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
(Date:9/7/2017)... nearly two decades, New Life Agency has been committed to providing the ... Life Agency announces a powerful three-way partnership designed to deliver substantial savings ... ... http://www.schrafts2.com/ (PRNewsfoto/PharmaCareCard) ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... Sept. 7, 2017 NuvoAir (formerly called ... announced today a partnership with Novartis Pharma AG to distribute ... position as the leading mobile spirometry platform and Novartis, commitment ... ... ...
Breaking Medicine Technology: